Probiotics in the Treatment of Colorectal Cancer
AbstractThe human microbiome plays many roles in inflammation, drug metabolism, and even the development of cancer that we are only beginning to understand. Colorectal cancer has been a focus for study in this field as its pathogenesis and its response to treatment have both been linked to the functioning of microbiota. This literature review evaluates the animal and human studies that have explored this relationship. By manipulating the microbiome with interventions such as probiotic administration, we may be able to reduce colorectal cancer risk and improve the safety and effectiveness of cancer therapy even though additional clinical research is still necessary. View Full-Text
Share & Cite This Article
Hendler, R.; Zhang, Y. Probiotics in the Treatment of Colorectal Cancer. Medicines 2018, 5, 101.
Hendler R, Zhang Y. Probiotics in the Treatment of Colorectal Cancer. Medicines. 2018; 5(3):101.Chicago/Turabian Style
Hendler, Robert; Zhang, Yue. 2018. "Probiotics in the Treatment of Colorectal Cancer." Medicines 5, no. 3: 101.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.